159 related articles for article (PubMed ID: 16925138)
1. Individualizing care: treatment strategies for patients with myelodysplastic syndromes or multiple myeloma and nonhematologic comorbidities.
Biedrzycki BA
ONS News; 2006; 21(8 Suppl):25-6. PubMed ID: 16925138
[No Abstract] [Full Text] [Related]
2. MDS: navigating the complex course.
Fortenbaugh C
ONS News; 2006; 21(8 Suppl):17-8. PubMed ID: 16925134
[No Abstract] [Full Text] [Related]
3. Advances in the treatment of MDS, multiple myeloma, and CLL.
Snively A
ONS Connect; 2007; 22(8 Suppl):55-6. PubMed ID: 17824566
[No Abstract] [Full Text] [Related]
4. Advances in the treatment of multiple myeloma: a nursing perspective.
Barrick M
ONS News; 2006; 21(8 Suppl):15-6. PubMed ID: 16925133
[No Abstract] [Full Text] [Related]
5. Nursing considerations for nontraditional treatment approaches to hematologic malignancies.
ONS News; 2004; 19(9 Suppl):67-8. PubMed ID: 15478594
[TBL] [Abstract][Full Text] [Related]
6. Advances and new challenges in multiple myeloma.
Kurtin S
Oncology (Williston Park); 2011 Apr; 25(4 Suppl Nurse Ed):33-4. PubMed ID: 25391204
[No Abstract] [Full Text] [Related]
7. Advancing access to myeloma treatment: administration, side effects, and implications for survival.
Davies MJ
ONS News; 2006; 21(8 Suppl):11-2. PubMed ID: 16925131
[No Abstract] [Full Text] [Related]
8. Current diagnosis and management of multiple myeloma.
Rome S
Oncology (Williston Park); 2011 Apr; 25(4 Suppl Nurse Ed):14-9, 26-32. PubMed ID: 25391203
[TBL] [Abstract][Full Text] [Related]
9. Future frontiers in the treatment of myelodysplastic syndromes.
ONS News; 2004; 19(9 Suppl):19-20. PubMed ID: 15478571
[TBL] [Abstract][Full Text] [Related]
10. Patient-driven, evidence-based treatment for breast, lung, and prostate cancer.
King CR
ONS News; 2006; 21(8 Suppl):33-4. PubMed ID: 16925142
[No Abstract] [Full Text] [Related]
11. Emerging therapies in head and neck cancers: EGFR inhibitors.
Held-Warmkessel J
ONS News; 2006; 21(8 Suppl):61-2. PubMed ID: 16925156
[No Abstract] [Full Text] [Related]
12. Case studies in metastatic bone disease: understanding the unique nature of bone loss due to malignancy.
Barrick M
ONS News; 2006; 21(8 Suppl):51-2. PubMed ID: 16925151
[No Abstract] [Full Text] [Related]
13. Going forward.
Harvey CD; Stovall EL
Am J Nurs; 2007 Apr; 107(4):13. PubMed ID: 17413712
[No Abstract] [Full Text] [Related]
14. Unraveling the mysteries of MDS: linking science to practice through case studies.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):61-2. PubMed ID: 17824569
[No Abstract] [Full Text] [Related]
15. Clinical updates and nursing considerations for patients with multiple myeloma.
Faiman B
Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
[TBL] [Abstract][Full Text] [Related]
16. Case-based discussion for the management of metastatic colorectal cancer.
Biedrzycki BA
ONS News; 2006; 21(8 Suppl):31-2. PubMed ID: 16925141
[No Abstract] [Full Text] [Related]
17. Expanding nursing expertise in targeted therapy.
Morse L
ONS News; 2006; 21(8 Suppl):55-6. PubMed ID: 16925153
[No Abstract] [Full Text] [Related]
18. Survivorship care planning: one size does not fit all.
Klemp JR
Semin Oncol Nurs; 2015 Feb; 31(1):67-72. PubMed ID: 25636397
[TBL] [Abstract][Full Text] [Related]
19. The treatment and management of patients who have myeloma.
King T; Morris M
Nurs Times; 2004 Jun 22-28; 100(25):30-1. PubMed ID: 15318658
[TBL] [Abstract][Full Text] [Related]
20. Treating hematologic malignancies: barriers to care.
Shonkwiler E
ONS News; 2006; 21(8 Suppl):23-4. PubMed ID: 16925137
[No Abstract] [Full Text] [Related]
[Next] [New Search]
